Oncozene Microspheres 40UM, 2ML, Oncozene Microspheres 75UM, 2ML, Oncozene Microspheres 100UM, 2ML, Oncozene Microsphere
Device, Vascular, For Promoting Embolization. 510(k) K130307, from Celonova Biosciences, Inc. (San Antonio, TX). Product code KRD, class 2.
As of Nov 19, 2026, K130307 is an FDA 510(k) held by Celonova Biosciences, Inc., substantially equivalent on Mar 4, 2013 after 25 days, with no recalls tied to it in FDA's recall database.
- Review time: 25 days
- Recalls: 0
- Cited as a predicate by: 1 device
. K130307 Device Name Vascular Embolization Device Indications for Use ONCOZENE™ Microspheres are indicated for the embolization of hypervascular tumors and arteriovenous malformations.
- Embozene MicrospheresK073417 · Celonova Biosciences, Inc. · Dec 15, 2008
- Embozene Color-Advanced Microspheres, Embozene Opaque (Non-Colored) Microspheres, Oncozene MicrospheresK141209 · Celonova Biosciences, Inc. · Aug 7, 2014
- LOBO Vascular Occlusion SystemK262798 · Okami Medical, Inc. · Oct 6, 2026
- UniPearls® Embolic MicrospheresK252812 · Suzhou Haowei Medical Technology Co., Ltd. · Jul 31, 2026
- OBSIDIO Conformable EmbolicK261488 · Boston Scientific Corporation · Jul 24, 2026
- Concerto Versa™ Detachable CoilK261866 · Medtronic, Inc. · Jun 24, 2026
- HARBOR Occlusion DeviceK260635 · Nuvascular, Inc. · Jun 12, 2026
- LOBO Vascular Occlusion SystemK260508 · Okami Medical, Inc. · Apr 10, 2026
- Concerto Versa™ Detachable CoilK253511 · Medtronic, Inc. · Jan 14, 2026
- Tembo Embolic SystemK253677 · Instylla, Inc. · Dec 15, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Feb 7, 2013
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files